CD274 and neoplasm: The expression of PD-L1 has been seen as a prognostic biomarker, which is expressed in 30 to 65% of invasive GCs, and is associated with some factors, such as EBV infection, tumor size, tumor depth of invasion, lymph nodes, and distant metastasis [24–26].